Maria Luisa Pedro-Botet
Head of Section for immunosuppressed and severe bacteria
Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
170€
There is currently an exponential increase in the use of biological therapy directed at specific molecular targets, which has led to the recovery or stabilization of several autoimmune or neoplastic diseases that were incurable until a few years ago. This has led to the massive use of this type of drugs by many specialists.
The second edition of the workshop aims to provide an update on the mechanisms of primary and secondary antibody deficiencies, as well as to deepen the management and treatment and analyze the impact of COVID-19 in PIDs.
Head of Section for immunosuppressed and severe bacteria
Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Head of COVID-19 Section
Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Specialist physician
Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Specialist physician
Hospital Universitari i Politècnic La Fe, Valencia, Spain
Nurse
Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Specialist physician
Hospital Universitari Vall d’Hebron, Barcelona, Spain.
Activity accredited by the Consell Català de Formació Continua de les Professions Sanitàries-Comisión de Formación Continuada de Sistema Nacional de Salud. 0,7 Credits. Record: 09/034661-MD